文献速递乳腺癌

动态糖蛋白低唾液酸化促进乳腺癌静止循环肿瘤细胞簇的化疗逃逸与转移种植

Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer.
PubMed 文献 · Cancer Discov · 2023-01-01

该研究报道乳腺癌循环肿瘤细胞(CTC)单细胞与细胞簇动态可预测总生存;化疗逃逸的CTC簇相对静止,伴ST6GAL1催化的α2,6-唾液酸化丢失;糖蛋白低唾液酸化促进簇形成与转移种植,并实现细胞静止以逃逸紫杉醇治疗。

要点

  • 乳腺癌CTC单细胞与细胞簇动态可预测总生存。
  • 化疗逃逸的CTC簇相对静止,伴ST6GAL1催化的α2,6-唾液酸化丢失。
  • 抗PODXL中和抗体可抑制三阴性乳腺癌紫杉醇治疗相关的CTC簇形成与肺转移。

核心结论

  • CTC簇糖蛋白末端唾液酸化动态丢失贡献细胞休眠命运、有利的化疗逃逸及增强的转移种植。
  • PODXL被鉴定为ST6GAL1的糖蛋白底物及对抗静止肿瘤细胞化疗逃逸相关转移的候选靶点。

研究设计与样本

  • 研究纳入乳腺癌CTC单细胞与细胞簇动态分析,评估其对总生存的预测。
  • 采用糖蛋白组学分析鉴定ST6GAL1的新蛋白底物。
  • 以抗PODXL中和抗体进行概念验证,观察三阴性乳腺癌紫杉醇治疗相关CTC簇形成与肺转移。

主要发现

  • 多细胞簇中具有干性的CTC较单细胞具有20至100倍更高的转移倾向。
  • 化疗逃逸的CTC簇相对静止,伴ST6GAL1催化的α2,6-唾液酸化在糖蛋白中的特异性丢失。
  • CTC中动态低唾液酸化或ST6GAL1缺陷促进簇形成以利转移种植,并实现细胞静止以逃逸紫杉醇治疗。
  • 糖蛋白组学揭示ST6GAL1新蛋白底物包括PODXL、ICAM1、ECE1、ALCAM1、CD97和CD44,贡献CTC聚集与转移种植。
  • 抗PODXL中和抗体抑制三阴性乳腺癌紫杉醇治疗相关的CTC簇形成与肺转移。

关键数值与推荐

  • 多细胞簇中具有干性的CTC转移倾向较单细胞高20至100倍。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Most circulating tumor cells (CTC) are detected as single cells, whereas a small proportion of CTCs in multicellular clusters with stemness properties possess 20- to 100-times higher metastatic propensity than the single cells. Here we report that CTC dynamics in both singles and clusters in response to therapies predict overall survival for breast cancer. Chemotherapy-evasive CTC clusters are relatively quiescent with a specific loss of ST6GAL1-catalyzed α2,6-sialylation in glycoproteins. Dynamic hyposialylation in CTCs or deficiency of ST6GAL1 promotes cluster formation for metastatic seeding and enables cellular quiescence to evade paclitaxel treatment in breast cancer. Glycoproteomic analysis reveals newly identified protein substrates of ST6GAL1, such as adhesion or stemness markers PODXL, ICAM1, ECE1, ALCAM1, CD97, and CD44, contributing to CTC clustering (aggregation) and metastatic seeding. As a proof of concept, neutralizing antibodies against one newly identified contributor, PODXL, inhibit CTC cluster formation and lung metastasis associated with paclitaxel treatment for triple-negative breast cancer. SIGNIFICANCE: This study discovers that dynamic loss of terminal sialylation in glycoproteins of CTC clusters contributes to the fate of cellular dormancy, advantageous evasion to chemotherapy, and enhanced metastatic seeding. It identifies PODXL as a glycoprotein substrate of ST6GAL1 and a candidate target to counter chemoevasion-associated metastasis of quiescent tumor cells. This article is featured in Selected Articles from This Issue, p. 1949.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Dashzeveg NK, Jia Y, Zhang Y, et al. Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer. Cancer Discov. 2023. PMID: 37272843. doi:10.1158/2159-8290.CD-22-0644

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。